BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29221155)

  • 1. CD109 released from human bone marrow mesenchymal stem cells attenuates TGF-β-induced epithelial to mesenchymal transition and stemness of squamous cell carcinoma.
    Zhou S; Cecere R; Philip A
    Oncotarget; 2017 Nov; 8(56):95632-95647. PubMed ID: 29221155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD109 acts as a gatekeeper of the epithelial trait by suppressing epithelial to mesenchymal transition in squamous cell carcinoma cells in vitro.
    Zhou S; da Silva SD; Siegel PM; Philip A
    Sci Rep; 2019 Nov; 9(1):16317. PubMed ID: 31695056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow - mesenchymal stem cells impact on the U937 cells in the presence of staphylococcal enterotoxin B (SEB).
    Ejtehadifar M; Halabian R; Ghazavi A; Khansarinejad B; Mosayebi G; Imani Fooladi AA
    Clin Exp Pharmacol Physiol; 2018 Aug; 45(8):849-858. PubMed ID: 29655181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD109 release from the cell surface in human keratinocytes regulates TGF-β receptor expression, TGF-β signalling and STAT3 activation: relevance to psoriasis.
    Litvinov IV; Bizet AA; Binamer Y; Jones DA; Sasseville D; Philip A
    Exp Dermatol; 2011 Aug; 20(8):627-32. PubMed ID: 21539622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD109 attenuates TGF-β1 signaling and enhances EGF signaling in SK-MG-1 human glioblastoma cells.
    Zhang JM; Murakumo Y; Hagiwara S; Jiang P; Mii S; Kalyoncu E; Saito S; Suzuki C; Sakurai Y; Numata Y; Yamamoto T; Takahashi M
    Biochem Biophys Res Commun; 2015 Apr; 459(2):252-258. PubMed ID: 25724945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of TGF-β/Smad signaling by BAMBI blocks differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and abolishes their protumor effects.
    Shangguan L; Ti X; Krause U; Hai B; Zhao Y; Yang Z; Liu F
    Stem Cells; 2012 Dec; 30(12):2810-9. PubMed ID: 23034983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chondrogenesis of human bone marrow-derived mesenchymal stem cells in agarose culture.
    Huang CY; Reuben PM; D'Ippolito G; Schiller PC; Cheung HS
    Anat Rec A Discov Mol Cell Evol Biol; 2004 May; 278(1):428-36. PubMed ID: 15103737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble CD109 binds TGF-β and antagonizes TGF-β signalling and responses.
    Li C; Hancock MA; Sehgal P; Zhou S; Reinhardt DP; Philip A
    Biochem J; 2016 Mar; 473(5):537-47. PubMed ID: 26621871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-17A increases leptin production in human bone marrow mesenchymal stem cells.
    Noh M
    Biochem Pharmacol; 2012 Mar; 83(5):661-70. PubMed ID: 22197587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of SIRT6 Enables Human Bone Marrow Mesenchymal Stem Cell Senescence.
    Zhai XY; Yan P; Zhang J; Song HF; Yin WJ; Gong H; Li H; Wu J; Xie J; Li RK
    Rejuvenation Res; 2016 Oct; 19(5):373-384. PubMed ID: 26654351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunomodulatory properties of human bone marrow-derived mesenchymal stromal cells are defined according to multiple immunobiological criteria.
    Fayyad-Kazan H; Faour WH; Badran B; Lagneaux L; Najar M
    Inflamm Res; 2016 Jun; 65(6):501-10. PubMed ID: 26956767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Processing of CD109 by furin and its role in the regulation of TGF-beta signaling.
    Hagiwara S; Murakumo Y; Mii S; Shigetomi T; Yamamoto N; Furue H; Ueda M; Takahashi M
    Oncogene; 2010 Apr; 29(15):2181-91. PubMed ID: 20101215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of IGF-I in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-beta signaling.
    Longobardi L; O'Rear L; Aakula S; Johnstone B; Shimer K; Chytil A; Horton WA; Moses HL; Spagnoli A
    J Bone Miner Res; 2006 Apr; 21(4):626-36. PubMed ID: 16598383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of human bone marrow mesenchymal stem cells on invasion of tongue squamous cell carcinoma cell line Cal-27].
    Xu ZQ; Zhang XY; Wang SR; Li T; Dong G; Li FM; Zheng JJ; Wang YY; Xu XN
    Shanghai Kou Qiang Yi Xue; 2020 Apr; 29(2):155-161. PubMed ID: 32626878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Function-Enhanced Mesenchymal Stem Cells Infected With Decorin-Expressing Adenovirus on Hepatic Fibrosis.
    Jang YO; Cho MY; Yun CO; Baik SK; Park KS; Cha SK; Chang SJ; Kim MY; Lim YL; Kwon SO
    Stem Cells Transl Med; 2016 Sep; 5(9):1247-56. PubMed ID: 27365486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electromagnetic fields and nanomagnetic particles increase the osteogenic differentiation of human bone marrow-derived mesenchymal stem cells.
    Kim MO; Jung H; Kim SC; Park JK; Seo YK
    Int J Mol Med; 2015 Jan; 35(1):153-60. PubMed ID: 25352086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effects of bone marrow-derived mesenchymal stem cells on radiation-induced lung injury.
    Xia C; Chang P; Zhang Y; Shi W; Liu B; Ding L; Liu M; Gao L; Dong L
    Oncol Rep; 2016 Feb; 35(2):731-8. PubMed ID: 26717975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD109: a multifunctional GPI-anchored protein with key roles in tumor progression and physiological homeostasis.
    Mii S; Enomoto A; Shiraki Y; Taki T; Murakumo Y; Takahashi M
    Pathol Int; 2019 May; 69(5):249-259. PubMed ID: 31219232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Bone Marrow Mesenchymal Stem Cells Promote Gastric Cancer Growth via Regulating
    Chen B; Yu J; Wang Q; Zhao Y; Sun L; Xu C; Zhao X; Shen B; Wang M; Xu W; Zhu W
    Stem Cells Int; 2018; 2018():9501747. PubMed ID: 30186330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-β1 suppresses bone morphogenetic protein-2-induced mesenchymal-epithelial transition in HSC-4 human oral squamous cell carcinoma cells via Smad1/5/9 pathway suppression.
    Chiba T; Ishisaki A; Kyakumoto S; Shibata T; Yamada H; Kamo M
    Oncol Rep; 2017 Feb; 37(2):713-720. PubMed ID: 28035402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.